After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health. The more people take our breakthrough blood tests, the more lives we can save. Life over cancer.


Publications & Abstracts


Issued Patents




Commercial Samples

Enabling Better Outcomes Today

We are preventing and detecting cancer early even before symptoms appear with highly accurate, clinically validated, routine blood-draw based tests to detect and analyze rare tumor cells (CTCs).

Accelerating Research

We are partnering with researchers and drug developers worldwide, to discover and commercialize novel, non-invasive tests for cancer detection, treatment selection and monitoring

Early Detection Landscape

“We found the needle”

Our proprietary platform- microfluidic chip, antibody, and imaging software- has enabled us to be the only company to overcome the “intractable” challenge of detecting rare CTCs in pre-cancer and early stage patients, when cancer can be successfully treated.

Technology limitations have restricted other CTC and ctDNA technologies to advanced cancers when it is unfortunately too late to impact outcome for most patients.

Prediction - Detection - Monitoring

Patented Biomarker Technologies

We are unique in having expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) technologies. Providing precision medicine solutions for healthy people and patients diagnosed with cancer.  And tests that guide physicians in treating their patient at the right time, and with the right treatment, based on their patient’s tumor profile.

People are Talking

What the world’s most trusted sources are saying about CellMax Life cancer testing.

CellMax Life

CellMax Life is a leading cancer diagnostics company whose mission is to transform how cancer is diagnosed and managed with globally affordable non-invasive tests for early cancer detection and management. CellMax’s unique expertise in both Circulating Tumor Cell and Next Generation Sequencing of DNA and circulating tumor DNA (ctDNA) has enabled multiple highly effective precision medicine solutions for healthy people as well as patients diagnosed with cancer.

U.S. Headquarters

1271 Oakmead Parkway Sunnyvale, CA 94085 Phone: +1 650-564-3905

Taiwan Office

18F-1 Park Street Nangkang, Taipei City (+886) 0800-555-885 (Taiwan)

© 2018 CellMax Life | All Rights Reserved | Terms and Conditions | Privacy Policy